CBD content in topical products largely inconsistent with label claims, says Leafreport
Results showed that a 31 of the 40 products (77.5%) tested did not contain the amount of CBD claimed on the label.
Photo © iStockphoto.com/marylooo
Leafreport, a CBD educational platform, released a study evaluating the accuracy of CBD claims on topical products. Through a third-party testing lab, called Canalysis Laboratories (Las Vegas, NV) 40 CBD topical products from various popular and less-known CBD brands were evaluated. Results showed that a 31 of the 40 products (77.5%) did not contain the amount of CBD claimed on the label. In fact, only 9 of the products (22.5%) contained within 10% of the label claims. Eight of the product contained more CBD than stated, while one contained less.
The 31 CBD topicals that were not within 10% of CBD label claims diverged in varying degree. For example, 14 of the products contained within 20% of CBD claimed on the label. Of these 12 contained more than stated on the label, and two contained less. The worse 11 products diverged more than 30% from label claims. Of these, five products contained more CBD than stated on the label, and six contained less.
Leafreport found similar results when independently testing CBD beverages. Sample testing by FDA has also shown inconsistency, with the agency committing to a long-term sampling plan to determine the extent of adulteration in the market.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
